Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HTR7 | P34969 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 4/20 | 0.40 |
| ▸ | DRD4 | P21917 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.36 |
| ▸ | GABRD | O14764 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29848427 | 1.00 | PNMT (0.54) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL29368791 | 1.00 | PNMT (0.54) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| Benzene SCHEMBL28021305 | 0.99 | PNMT (0.53) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| Acetonitrile SCHEMBL28942670 | 0.92 | PNMT (0.47) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL28811896 | 0.91 | PNMT (0.46) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL27921405 | 0.89 | PNMT (0.49) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL7000069 | 0.89 | PNMT (0.51) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL1830397 | 0.88 | PNMT (0.57) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL1830400 | 0.87 | PNMT (0.55) | PNMTNPC1RAB9AALDH1A1HTR7 | |
| SCHEMBL8671794 | 0.87 | PNMT (0.55) | PNMTNPC1RAB9AALDH1A1HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121570433-A | Glutamine metabolism regulation nano drug delivery system for enhancing pancreatic cancer targeting and penetration, and preparation method and application thereof | 复旦大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250270177-A1 | PURIFICATION METHOD FOR ELECTRON MEDIATOR | LEADWAY (HK) LIMITED (CN) | 2025-08-28 | — | — | US | claimed |
| CN-120058715-A | Intermediate of RHYNCHINES A compound and synthesis method thereof | 河北科技大学 | 2025-05-30 | — | — | CN | claimed |
| CN-116730849-B | Preparation method of optically active [1- (1-amino ethyl) cyclopropyl ] methanol | 江苏艾迪药业股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| WO-2025083736-A1 | NOVEL PROCESS FOR THE PREPARATION OF PIRTOBRUTINIB AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-04-24 | — | — | WO | claimed |
| US-20250109415-A1 | SUSTAINABLE FUNCTIONALIZATION AND METHODS OF USE THEREOF | UNIV ARIZONA STATE (US) | 2025-04-03 | — | — | US | claimed |
| CN-119264549-B | Scratch-resistant PE composite board and preparation method thereof | 上犹县穗联工程塑料厂(普通合伙) | 2025-03-28 | — | — | CN | claimed |
| CN-116375789-B | Antitumor compound, preparation method thereof, pharmaceutical composition and application | 北京大学第一医院 | 2025-03-21 | — | — | CN | claimed |
| EP-4512802-A1 | PURIFICATION METHOD FOR ELECTRON MEDIATOR | Leadway (HK) Limited (CN) | 2025-02-26 | — | — | EP | claimed |
| WO-2025007401-A1 | CONSTRUCT FOR REAL-TIME TRACING OF SPATIAL GENOME CONFORMATION AND TRANSCRIPTION PRODUCTS IN LIVING CELLS AND USE THEREOF | 生物岛实验室 | 2025-01-09 | — | — | WO | claimed |
| US-20040236104-A1 | Substituted 4-aminocyclohexanols | GRUENENTHAL GMBH (DE) | 2004-11-25 | — | — | US | claimed |
| US-20040214822-A1 | Substituted 4-aminocyclohexanol compounds | GRUENENTHAL GMBH (DE) | 2004-10-28 | — | — | US | claimed |
| EP-0589004-A1 | PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM | N.V. INNOGENETICS S.A. (BE) | 1994-03-30 | — | — | EP | claimed |
| WO-1993018054-A2 | PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM | N.V. INNOGENETICS S.A. (BE) | 1993-09-16 | — | — | WO | claimed |
| EP-0530252-A4 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | US HEALTH (US) | 1993-09-01 | — | — | EP | claimed |
| EP-0530252-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE (US) | 1993-03-10 | — | — | EP | claimed |
| EP-0277561-B1 | NEW ARGININE DERIVATIVE, PROCESS FOR THE PREPARATION THEREOF AND ITS USE IN PEPTIDE SYNTHESIS | ENIRICERCHE S.p.A. (IT) | 1992-04-15 | — | — | EP | claimed |
| WO-1991017154-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-11-14 | — | — | WO | claimed |
| EP-0233973-B1 | MIXTURE OF AMINO ACID DERIVATIVES, PROCESS OF PRODUCING THE MIXTURE AND USE OF THE MIXTURE FOR QUANTITATIVE DETERMINATION OF THE AMINO ACIDS | Hewlett-Packard GmbH (DE) | 1990-12-27 | — | — | EP | claimed |
| EP-0277561-A1 | New arginine derivative, process for the preparation thereof and its use in peptide synthesis | ENIRICERCHE S.p.A. (IT) | 1988-08-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214822-A1 | Substituted 4-aminocyclohexanol compounds | ADRA2C, OPRD1, OPRK1 | PNMT 254/4885NPC1 740/4885RAB9A 2326/4885 |
| US-20250270177-A1 | PURIFICATION METHOD FOR ELECTRON MEDIATOR | MB, DAO, BCAT2 | PNMT 78/4885NPC1 4354/4885RAB9A 3087/4885 |
| US-20040236104-A1 | Substituted 4-aminocyclohexanols | CNR2, OPRK1, OPRL1 | PNMT 270/4885NPC1 1020/4885RAB9A 3382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.